the aid library

LIST OPTIONS

Filter

7796

G2H2 Report on Financial Justice for Pandemic Prevention, Preparedness and Response

Geneva Global Health Hub (2022) CC

A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti... more

Download (290)

View PDF (601)

Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System

World Health Organization (2011) C_WHO

Policy Statement

Download (559)

View PDF (732)

Integrated Communication Strategy for the Introduction of Oral Cholera Vaccine in Cholera Prevention and Control Programmes

UNICEF (2014)

External Link

Donor Financing of Global Mental Health, 1995—2015: An Assessment of Trends, Channels, and Alignment with the Disease Burden

Charlson, F.J.; J. Dieleman, L. Singh et al. PLOS One (2017) CC

Background: A recent report by the Institute for Health Metrics and Evaluation (IHME) highlights that mental health receives little attention despite being a major cause of disease burden. This paper extends previous assessments of development assistance for mental health (DAMH) in two significant w... more

Download (1427)

View PDF (2364)

Liste temporaire de l'OMS des dispositifs médicaux pour les soins Ebola- dispositifs médicaux (n'incluant pas les équipements de protection individuelle)

Organisation Mondiale de la Santé OMS (2014)

Download (699)

View PDF (1669)

Pandemic influenza preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits

World Health Organization WHO (2022) C_WHO

2nd edition . This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ... more

Download (628)

View PDF (1833)

Guidelines for Cunducting Clinical Trials of Medicines, Food Supplements, Vaccines, and Medical Devices in Sierra Leone

Pharmacy Board Sierra Leone (2014) C1

Download (1002)

View PDF (1867)

Clinical Management of Rape Survivors: Developing protocols for use with refugees and internally displaced persons (Arabic edition)

UNHCR; WHO; UNFPA (2004) C_WHO

Download (374)

View PDF (349)

The distinctive role of the Catholic Church in development and humanitarian response: 7 ways the Church makes a difference

Catholic Agency for Overseas Development CAFOD (2021) CC

7 Febr. 2021 As COVID-19 continues to wreak havoc in countries – decimating people’s livelihoods, and leaving health systems struggling to provide healthcare and vaccines for the entire population - governments and donors should look to the Church as a partner. The essential Church networks, tr... more

Download (440)

View PDF (569)

Research Seminar on Child Education Policy in Indonesia: Towards Evidence-Based Policy Development (English and Indonesian Version)

The SMERU Research Institute, UNICEF (2012)

Download (804)

View PDF (1145)

Ebola Outbreak in West Africa: Lessons Learned from Quarantine – Sierra Leone and Liberia

Assessment Capacities Project (2015)

Summary of lessons learned Self-imposed quarantine has proved less problematic. The timely and reliable delivery of resources (e.g. food/water) and expertise (e.g. contact tracing/safe and dignified burials) is essential to ensure cooperation and deter quarantine violation. The commun... more

External Link

Social Pathways for Ebola Virus Disease in Rural Sierra Leone, and Some Implications for Containment

Richards, P.; et al. (2015)

Download (354)

View PDF (501)

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (1016)

View PDF (866)

Evaluation of the Capacity Project's Human Resources Information Systems (HRIS) Strengthening Process in Swaziland, Uganda and Rwanda

de Vries D, Blair G, Morgan K (2009) C2

The Capacity Project worked to strengthen HRIS in several low-resource countries to assist decision-makers and human resources managers in identifying and responding to critical gaps in HRH. The findings and recommendations in this report cover the Capacity Project’s implementation of HRIS in Swaz... more

Download (344)

View PDF (600)

The Cost of Integrated Community Case Management in Nguelemendouka and Doumé Districts, Cameroon

Management Sciences for Health (2014) C1

External Link

Role of APOC in the new strategic direction for Onchocerciasis elimination, co-implementation with Lymphatic filariasis and other health interventions

World Health Organization WHO; African Programme for Onchocerciasis Control APOC (2012) C_WHO

The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ... more

External Link

Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Global Research on Developmental Disabilities Collaborators (2018) CC

The Lancet Global Health, Vol. 6, No. 10 Published: August 29, 2018

Download (684)

View PDF (1133)

HIV Epidemic Appraisals in Nigeria: Evidence for Prevention Programme Planning and Implementation: Data from the first eight States

Federal Ministry of Health, Nigeria; National Agency for the Control of Aids (NACA) (2013) C1

Download (332)

View PDF (329)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more